Patient Care

LogicSource recognized as one of Modern Healthcare’s Best in Business 2024

WESTPORT, Conn., Dec. 9, 2024 /PRNewswire/ -- LogicSource, the leader in procurement services and technology solutions, is proud to announce…

2 weeks ago

Get Well Earns 2024 Fierce Healthcare Diversity, Equity, and Inclusion Award

Recognition highlights Get Well's maternal health equity and youth mental health programs BETHESDA, Md., Dec. 9, 2024 /PRNewswire/ -- Get…

2 weeks ago

CipherHealth Recognized as One of Modern Healthcare’s Best in Business

CipherHealth named a recipient of the 2024 Best in Business Awards in the Patient Experience & Engagement category NEW YORK,…

2 weeks ago

Arrive AI Revolutionizes Healthcare Logistics with Smart, Secure Delivery Hubs

Patented Technology Ensures Chain of Custody, Climate Control and Seamless Integration with Robots and Drones INDIANAPOLIS, Dec. 9, 2024 /PRNewswire/…

2 weeks ago

Hot Topics in Neonatology® 2024 Conference to Feature Symposium on Clinical Impact & Cost Savings of an Exclusive Human Milk Diet

Dr. Jenny Fox From Children's Hospital of Richmond at Virginia Commonwealth University to Present Published Data and Firsthand Insights on…

2 weeks ago

Steven T. Boyd to Speak at PBM Contracting Summit

Presentation offers insights into legislative issues and the evolving PBM regulatory horizonNatchitoches, Louisiana--(Newsfile Corp. - December 9, 2024) - Steven…

2 weeks ago

T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

Intends to accelerate broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue streamLEXINGTON, Mass., Dec.…

2 weeks ago

Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision

DALLAS, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI)…

2 weeks ago

NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics’ Prolaris® Test as an ‘Advanced Tool’ Recommended for Prognostic Assessment

Prolaris Remains a Long-Standing Fixture in the Guidelines for 10th Year RunningSALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) --…

2 weeks ago